| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.2M | +7.9% | +4.4% |
| R&D Expense | $20.0M | -8.2% | -19.0% |
| SG&A Expense | $6.7M | -3.1% | -4.6% |
| Operating Income | -$18.5M | +12.3% | +22.4% |
| Net Income | -$15.8M | +11.6% | +17.1% |
| EPS (Basic) | -$0.25 | +10.7% | +19.4% |
| EPS (Diluted) | -$0.25 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $89.3M | +23.1% | +54.9% |
| Current Assets | $184.1M | -9.7% | -32.1% |
| Total Assets | $205.0M | -9.4% | -33.5% |
| Current Liabilities | $85.1M | +9.4% | +49.7% |
| Total Liabilities | $294.6M | -2.7% | -12.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$63.8M | — | — |
| Capital Expenditures | $50K | — | — |
| Investing Cash Flow | $98.8M | — | — |
| Financing Cash Flow | $442K | — | — |
| Free Cash Flow | -$63.9M | — | — |
| +10.7% |
| +19.4% |
| -$89.7M |
| -17.0% |
| -217.0% |